Browsing: peregrine pharmaceuticals

Approximately 19,000 individuals in the US are diagnosed with primary brain cancers each year.

Peregrine Pharmaceuticals reported positive Phase II data in a clinical trial of bavituximab in patients with a deadly form of lung cancer.